Back

Transcatheter pulmonary valve implantation experience in a Portuguese congenital heart disease center

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in interventional cardiology (1) Noncoronary Cardiac Intervention HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ana Isabel Pinho

Sao Joao University Hospital Centre, Porto (Portugal)

5 More presentations in this session

Presentation thumbnail
Percutaneous PFO closure for cryptogenic stroke: a single-center experience
Miss I. Conde (Braga, PT)
Abstract Slides Video
Presentation thumbnail
Transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation: a meta-analysis of mortality outcomes
Doctor B. Lage Garcia (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Left ventricular ejection fraction improvement after transcatheter aortic valve replacement: predictors and prognosis
Doctor M. Paralta De Figueiredo (Evora, PT)
Abstract Slides Video
Presentation thumbnail
Comparative analysis of early stroke risk in transcatheter versus surgical aortic valve replacement in elderly patients: a systematic review and meta-analysis
Mr J. Al Hooti (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
In-hospital outcomes for TAVR under 75: can it hold a candle to SAVR?
Mr D. Inacio Cazeiro (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in interventional cardiology (1)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
A patient with Tetralogy of Fallot presenting with low NT-proBNP values and severe exercise intolerance – personalized heart failure treatment with percutaneous Venus valve implantation
thumbnail
Congress Presentation
The long journey of a tetralogy of Fallot patient
thumbnail
Congress Presentation
Valve-in-valve transcatheter aortic valve implantation in patients with failed bioprosthetic aortic valves: an analysis of safety, feasibility and clinical outcomes.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources